Smartwatch and AI to help detect obstructive sleep apnea
Tests a smartwatch-based AI model for spotting obstructive sleep apnea in adults.
Key facts
- Who runs it
- Seoul National University Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Smartwatch-Based AI Model for OSA Prediction (SWOSA)
- Status
- Recruiting
- People taking part
- 147 people, planned
- Started
- 3 Feb 2025
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- Galaxy Watch 4, Samsung Electronics Co., Ltd., South Korea
- Record updated
- 15 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who came to Seoul National University Hospital with suspected sleep apnea. Signs include snoring, pauses in breathing or strong daytime sleepiness. Participants wear a smartwatch during sleep.
- Age
- 22 to 85 years
- Sex
- Men and women
- Disease stage
- Suspected obstructive sleep apnea (breathing stops during sleep), not yet treated
- Earlier treatment
- People already diagnosed with sleep apnea and now being treated cannot join. This includes PAP therapy, mechanical ventilation, oral appliances or surgery.
Main reasons for not taking part
- Neuromuscular disease, or long-term use of opioid medicines
- Severe insomnia not controlled by medicine
- Extra oxygen therapy for another condition, or baseline oxygen saturation less than 90%
- Implanted pacemaker, defibrillator or other electronic device
- Pregnancy, or no experience using smartphones, apps or smartwatches
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Men and women aged 22 to 85 years who visited Seoul National University Hospital with suspected sleep apnea due to symptoms such as snoring, apnea, or excessive daytime sleepiness
Who cannot take part
- Patients previously diagnosed with sleep apnea who are currently undergoing treatment (e.g., positive airway pressure [PAP] therapy, mechanical ventilation, oral appliances, or surgery)
- Patients with severe insomnia that is not controlled by medication
- Patients receiving supplemental oxygen therapy due to underlying conditions such as heart failure, chronic obstructive pulmonary disease, interstitial lung disease, hypoventilation syndrome, or stroke, or whose baseline oxygen saturation is less than 90%
- Patients with neuromuscular diseases or a history of chronic opioid medication use
- Patients with implanted cardiac pacemakers, defibrillators, or other electronic devices
- Patients inexperienced in using smartphones, apps, or smartwatches
- Pregnant women
- Patients unable or unwilling to provide written informed consent
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 22 and 85 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to develop an artificial intelligence (AI) model for more accurately diagnosing obstructive sleep apnea (OSA) by collecting blood oxygen saturation and other health information during sleep using a smartwatch.
Read full original descriptionShow less
OSA is common but often underdiagnosed, and the gold-standard diagnostic test, polysomnography, is costly and time-consuming. Smartwatches can provide a variety of health data, such as sleep patterns, blood oxygen saturation, and heart rate, which can help detect key symptoms and signs of OSA.
By developing an AI model that uses smartwatch data to screen for OSA, this study seeks to offer a cost-effective and accessible diagnostic method, ultimately contributing to the early detection and improved treatment rates of OSA.
The group in the trial
- Smart Watch Group
Men and women aged 22 to 85 years who visited Seoul National University Hospital with suspected sleep apnea due to symptoms such as snoring, apnea, or excessive daytime.
Treatment: Galaxy Watch 4, Samsung Electronics Co., Ltd., South Korea
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Smartwatch-Based Artificial Intelligence Model for Obstructive Sleep Apnea Prediction
- Plain-language title
- Smartwatch and AI to help detect obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06792188, who can take part
- Record updated
- 15 May 2025